Adverse Drug Reaction Clinical Trial
Official title:
Implementation of a Hospital Pharmacovigilance Service and Comparison of Algorithms for Adverse Drug Reaction Causality Assessment
Spontaneous reports by health professionals generate the signals in pharmacovigilance. However, the passive method has limitations and the most important of them are the underreporting and the poor quality of data, hindering the causality assessment of adverse drug events (ADE). Therefore, the present study aimed to validate an educational intervention (EI) in pharmacovigilance for hospital health professionals, in order to analyze the impact on the knowledge, skill and attitude in ADE reporting. Investigators proposed a multifaceted EI which will be developed in four meetings with one hour each. The following activities will be carried out: application of a questionnaire to assess the knowledge, skill and attitude before and after EI; lecture; practical class and education material distribution. The answers of questionnaire are going to be analyzed using content analysis technique. The definitions of World Health Organization and the minimum and desired criteria to fill the ADE form, according to the Pan American Health Organization, are going to be considered gold-standard answers. The statistical test of Wilcoxon-Mann Whitney test for paired samples will be applied, in order to assess the impact of educational intervention on behavior of health professionals (ADE reporting). With the present study, the following hypotheses will be tested: H0= There is no difference between the numbers of ADE reported (behavior/attitudes) before and after the educational intervention. H1= The numbers of ADE reported before and after the educational intervention are different.
A quasi-experimental study with health professionals who acted in a general and public hospital of medium complexity with 104 beds will be performed. Investigators proposed an educational intervention, with the development of lecture and practical class, application of questionnaire before and after EI and the distribution of educational material. Activities will be developed in four meetings of one hour each one. In the first meeting, questionnaire will be applied, in order to assess knowledge, skills and attitudes in pharmacovigilance prior to EI. The instrument was elaborated based on previous studies. Second meeting will be comprise a lecture regarding the theoretical framework and importance of pharmacovigilance, and distribution of educational material, whose content includes the same issues of presentation. In the third meeting, a practical class will be performed to promote a discussion of a fictitious case of adverse drug reaction (ADR), in order to elucidate the correct fill of ADE form. In the fourth meeting, will be repeated the application of questionnaire, in order to assess the impact of EI. With the aim to verify change behavior of health professionals regarding pharmacovigilance activities, the number of ADE reports made prior and after intervention will be compared. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Suspended |
NCT02559960 -
Post-marketing Safety Surveillance of Breviscapine Powder-Injection : a Registry Study
|
||
| Completed |
NCT01946919 -
Post-Marketing Surveillance of the Cinepazide Maleate Injection: a Real World Study
|
||
| Recruiting |
NCT04154553 -
Pharmacogenetic Testing of Patients With Unwanted Adverse Drug Reactions or Therapy Failure
|
||
| Completed |
NCT01732302 -
Educational Intervention to Reduce Drug-related Hospitalizations in Elderly Primary Health Care Patients
|
N/A | |
| Completed |
NCT05224804 -
Pharmacists' Knowledge and Attitudes About ADRs Reporting and Pharmacovigilance Practice in Egyptian Hospitals
|
||
| Completed |
NCT02297126 -
A Prospective Trial to Assess Cost and Clinical Outcomes of a Clinical Pharmacogenomic Program
|
N/A | |
| Completed |
NCT03093818 -
PREemptive Pharmacogenomic Testing for Preventing Adverse Drug REactions
|
N/A | |
| Not yet recruiting |
NCT04568668 -
Evaluating ActionADE in Reducing Adverse Drug Reactions
|
N/A | |
| Recruiting |
NCT02012504 -
Antidepressant Monotherapy on Depressive and Anxiety Symptom in Chinese Patients
|
Phase 0 | |
| Completed |
NCT01872520 -
Post-marketing Safety Surveillance of the Injection of DanShenDuoFenSuanYan A Real World Study
|
N/A | |
| Completed |
NCT01467050 -
Prevention of Adverse Drug Events (ADEs) in Hospitalised Older Patients
|
Phase 4 | |
| Completed |
NCT01679964 -
Sustained Virological Suppression and Improvement of Adverse Events of Switching to Raltegravir Study
|
Phase 4 | |
| Completed |
NCT02094638 -
Post-Marketing Surveillance of the Tanreqing Injection: a Real World Study
|
N/A | |
| Recruiting |
NCT01906710 -
the Pharmacy Intervention Team Hospital-based (PITH) for People Study: Effect on Clinical and Economic Outcomes
|
N/A | |
| Completed |
NCT02888834 -
Serious Adverse Drug Reaction and Their Preventability
|
N/A | |
| Completed |
NCT02838212 -
Adverse Drug Reactions With Fatal Outcome
|
N/A | |
| Completed |
NCT02159209 -
The Drug Induced Renal Injury Consortium
|
N/A | |
| Completed |
NCT04553107 -
Reducing Costs by Deprescribing Medications
|
N/A | |
| Recruiting |
NCT06219720 -
The Texas Interprofessional Pharmacogenomics (IPGx)
|
||
| Recruiting |
NCT05508763 -
Personalised Therapeutics @LUMC
|